Retour

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Calendar Calendar of Events

CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting preclinical data from its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms have been accepted for presentation, including one oral presentation, at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place May 7-11, 2024 in Baltimore, MD.

GlobeNewswire Inc. • 22/04/2024 à 23:31:00
Generation Bio Co. Common Stock
Address: 301 BINNEY STREET
Postal Code: 02142
City: CAMBRIDGE
State: MA
Phone Number: 857-529-5908
Website: https://www.generationbio.com
Status: Active
Company Info

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

List Date2020-06-12
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001733294
Composite figiBBG00K698K88
Share Class figiBBG00K698K97
Market Cap192,783,622 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees174
Share Class Shares Outstanding66489999
Weighted Shares Outstanding66477111
Round Lot100
Updated date2024-04-28
Stats
Last 5 days
3-05
2-05
1-05
30-04
29-04
Last
3.165
3.118
2.91
2.83
2.855
Variance
1.77%
7.15%
2.83%
0.18%
-1.96%
Open
3.11
2.91
2.83
2.825
2.912
Highest
3.345
3.133
3.003
2.969
3.099
Lowest
3.345
3.13
2.995
2.92
3.055
History
PeriodVarhighestlowest
1 week
8.69%
3.099
2.92
1 month
-21.99%
4.269
2.92
3 month
69.25%
1.87
1.81
6 month
139.77%
1.37
1.02
1 year
-29.04%
4.64
0.86
3 year
-91.11%
35.59
0.86
5 year
-85.71%
24.9
0.86
10 year
-85.71%
24.9
0.86
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-02 2023-11-09 UNPUB
Assets 431,417,000 404,883,000 381,492,000 UNPUB
Current Assets 344,733,000 320,623,000 297,809,000 UNPUB
Current Liabilities 22,737,000 26,479,000 32,819,000 UNPUB
Equity 279,139,000 254,287,000 231,914,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 279,139,000 254,287,000 231,914,000 UNPUB
Liabilities 152,278,000 150,596,000 149,578,000 UNPUB
Liabilities And Equity 431,417,000 404,883,000 381,492,000 UNPUB
Noncurrent Assets 86,684,000 84,260,000 83,683,000 UNPUB
Noncurrent Liabilities 129,541,000 124,117,000 116,759,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-02 2023-11-09 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 2,479,000 49,320,000 -51,610,000 UNPUB
Net Cash Flow, Continuing 2,479,000 49,320,000 -51,610,000 UNPUB
Net Cash Flow From Financing Activities 35,772,000 99,000 -131,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 35,772,000 99,000 -131,000 UNPUB
Net Cash Flow From Investing Activities -5,616,000 24,415,000 -26,583,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -5,616,000 24,415,000 -26,583,000 UNPUB
Net Cash Flow From Operating Activities -27,677,000 24,806,000 -24,896,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -27,677,000 24,806,000 -24,896,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-02 2023-11-09 UNPUB
Comprehensive Income/Loss -31,977,000 -31,123,000 -28,247,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -31,977,000 -31,123,000 -28,247,000 UNPUB
Other Comprehensive Income/Loss 117,000 -57,000 19,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-10 2023-08-02 2023-11-09 UNPUB
Basic Earnings Per Share -1 0 0 UNPUB
Benefits Costs and Expenses UNPUB 31,946,000 30,412,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB 31,946,000 30,412,000 UNPUB
Diluted Earnings Per Share -1 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -32,094,000 -31,066,000 -28,266,000 UNPUB
Income/Loss From Continuing Operations Before Tax -32,094,000 -31,066,000 -28,266,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -32,094,000 -31,066,000 -28,266,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -32,094,000 -31,066,000 -28,266,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -32,094,000 -31,066,000 -28,266,000 UNPUB
Operating Expenses 34,866,000 34,799,000 33,503,000 UNPUB
Operating Income/Loss -34,866,000 -33,919,000 -31,357,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 880,000 2,146,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Assets UNPUB 418,994,000 402,799,000 376,264,000
Current Assets UNPUB 321,131,000 310,558,000 287,016,000
Current Liabilities UNPUB 16,185,000 17,318,000 19,150,000
Equity UNPUB 324,874,000 308,749,000 282,493,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 324,874,000 308,749,000 282,493,000
Liabilities UNPUB 94,120,000 94,050,000 93,771,000
Liabilities And Equity UNPUB 418,994,000 402,799,000 376,264,000
Noncurrent Assets UNPUB 97,863,000 92,241,000 89,248,000
Noncurrent Liabilities UNPUB 0 76,732,000 74,621,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -23,778,000 -281,974,000
Net Cash Flow, Continuing UNPUB UNPUB -23,778,000 -281,974,000
Net Cash Flow From Financing Activities UNPUB UNPUB 9,313,000 12,989,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 9,313,000 12,989,000
Net Cash Flow From Investing Activities UNPUB UNPUB -12,614,000 -192,515,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -12,614,000 -192,515,000
Net Cash Flow From Operating Activities UNPUB UNPUB -20,477,000 -102,448,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -20,477,000 -102,448,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Comprehensive Income/Loss UNPUB -38,268,000 -31,269,000 -136,722,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -38,268,000 -31,269,000 -136,722,000
Other Comprehensive Income/Loss UNPUB -339,000 37,000 -83,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2022-08-04 2022-11-03 2023-02-23
Basic Earnings Per Share UNPUB -1 -1 -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB -1 -1 -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -37,929,000 -31,306,000 -136,639,000
Income/Loss From Continuing Operations Before Tax UNPUB -37,929,000 -31,306,000 -136,639,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB -37,929,000 -31,306,000 -136,639,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -37,929,000 -31,306,000 -136,639,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -37,929,000 -31,306,000 -136,639,000
Operating Expenses UNPUB 38,481,000 32,669,000 141,182,000
Operating Income/Loss UNPUB -38,481,000 -32,669,000 -141,182,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-12 2021-08-11 2021-11-10 2022-02-24
Assets 514,081,000 490,792,000 464,033,000 476,771,000
Current Assets 455,785,000 432,741,000 403,270,000 379,186,000
Current Liabilities 10,794,000 13,931,000 14,506,000 18,808,000
Equity 458,736,000 433,402,000 407,210,000 381,746,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 458,736,000 433,402,000 407,210,000 381,746,000
Liabilities 55,345,000 57,390,000 56,823,000 95,025,000
Liabilities And Equity 514,081,000 490,792,000 464,033,000 476,771,000
Noncurrent Assets 58,296,000 58,051,000 60,763,000 97,585,000
Noncurrent Liabilities 0 0 42,317,000 76,217,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-12 2021-08-11 2021-11-10 2022-02-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 303,415,000 25,768,000 -84,000 315,897,000
Net Cash Flow, Continuing 303,415,000 25,768,000 -84,000 315,897,000
Net Cash Flow From Financing Activities 212,957,000 973,000 306,000 214,671,000
Net Cash Flow From Financing Activities, Continuing 212,957,000 973,000 306,000 214,671,000
Net Cash Flow From Investing Activities 113,485,000 50,232,000 22,165,000 193,047,000
Net Cash Flow From Investing Activities, Continuing 113,485,000 50,232,000 22,165,000 193,047,000
Net Cash Flow From Operating Activities -23,027,000 -25,437,000 -22,555,000 -91,821,000
Net Cash Flow From Operating Activities, Continuing -23,027,000 -25,437,000 -22,555,000 -91,821,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-12 2021-08-11 2021-11-10 2022-02-24
Comprehensive Income/Loss -25,561,000 -30,797,000 -31,858,000 -119,160,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -25,561,000 -30,797,000 -31,858,000 -119,160,000
Other Comprehensive Income/Loss 1,000 -6,000 -3,000 -9,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-12 2021-08-11 2021-11-10 2022-02-24
Basic Earnings Per Share UNPUB UNPUB UNPUB -2
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB -2
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -25,562,000 -30,791,000 -31,855,000 -119,151,000
Income/Loss From Continuing Operations Before Tax -25,562,000 -30,791,000 -31,855,000 -119,151,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -25,562,000 -30,791,000 -31,855,000 -119,151,000
Net Income/Loss Attributable To Noncontrolling Interest 38,000 0 0 0
Net Income/Loss Attributable To Parent -25,600,000 -30,791,000 -31,855,000 -119,151,000
Net Income/Loss Available To Common Stockholders, Basic -25,562,000 -30,791,000 -31,855,000 -119,151,000
Operating Expenses 25,655,000 30,842,000 31,658,000 119,101,000
Operating Income/Loss -25,655,000 -30,842,000 -31,658,000 -119,101,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic -38,000 0 0 0
Preferred Stock Dividends And Other Adjustments -38,000 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-10 2021-03-18
Assets UNPUB 331,202,000 310,922,000 294,155,000
Current Assets UNPUB 306,177,000 285,813,000 267,735,000
Current Liabilities UNPUB 11,536,000 9,163,000 11,220,000
Equity UNPUB 304,153,000 286,539,000 268,013,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 304,153,000 286,539,000 268,013,000
Liabilities UNPUB 27,049,000 24,383,000 26,142,000
Liabilities And Equity UNPUB 331,202,000 310,922,000 294,155,000
Noncurrent Assets UNPUB 25,025,000 25,109,000 26,420,000
Noncurrent Liabilities UNPUB 0 15,220,000 14,922,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-10 2021-03-18
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB -113,086,000 47,757,000
Net Cash Flow, Continuing UNPUB UNPUB -113,086,000 47,757,000
Net Cash Flow From Financing Activities UNPUB UNPUB -648,000 323,095,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -648,000 323,095,000
Net Cash Flow From Investing Activities UNPUB UNPUB -93,925,000 -205,196,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -93,925,000 -205,196,000
Net Cash Flow From Operating Activities UNPUB UNPUB -18,513,000 -70,142,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -18,513,000 -70,142,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-10 2021-03-18
Comprehensive Income/Loss UNPUB -17,735,000 -20,819,000 -80,514,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -17,735,000 -20,819,000 -80,514,000
Other Comprehensive Income/Loss UNPUB -4,000 30,000 9,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-11 2020-11-10 2021-03-18
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -17,731,000 -20,849,000 -80,523,000
Income/Loss From Continuing Operations Before Tax UNPUB -17,731,000 -20,849,000 -80,523,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB -17,731,000 -20,849,000 -80,523,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -17,731,000 -20,849,000 -80,523,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -17,731,000 -20,849,000 -80,523,000
Operating Expenses UNPUB 17,764,000 20,969,000 81,114,000
Operating Income/Loss UNPUB -17,764,000 -20,969,000 -81,114,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 0 0 0
Calendar
3 May 2024 (Time UTC) Actual Previous Consensus
★
19:45
United States
★★
19:45
United States
★
15:30
United States
-24500.000
-43400.000
★
15:30
United States
-162300.000
-154600.000
★
15:30
United States
54500.000
59300.000
★
15:30
United States
-150200.000
-132500.000
★★
15:30
United States
2800.000
6100.000
★
15:30
United States
-143400.000
-160200.000
★
15:30
United States
58100.000
58400.000
★
15:30
United States
1400.000
1300.000
★
15:30
United States
265500.000
264800.000
★
15:30
United States
43100.000
67700.000
★
15:30
United States
204200.000
202900.000
★★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:GBIO240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:GBIO240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:GBIO240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:GBIO240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:GBIO240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:GBIO240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:GBIO240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:GBIO240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:GBIO240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:GBIO240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:GBIO240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:GBIO240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:GBIO240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:GBIO240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:GBIO240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:GBIO240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:GBIO240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:GBIO240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:GBIO240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:GBIO240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:GBIO240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:GBIO240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:GBIO240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:GBIO240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:GBIO231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:GBIO231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:GBIO231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:GBIO231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:GBIO231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:GBIO231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:GBIO231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:GBIO231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:GBIO231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:GBIO231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:GBIO231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:GBIO231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:GBIO231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:GBIO231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:GBIO231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:GBIO231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:GBIO231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:GBIO231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:GBIO231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:GBIO231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:GBIO230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:GBIO230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:GBIO230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:GBIO230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:GBIO230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:GBIO230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:GBIO230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:GBIO230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:GBIO230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:GBIO230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:GBIO230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:GBIO230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:GBIO230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:GBIO230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:GBIO230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:GBIO230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting preclinical data from its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms have been accepted for presentation, including one oral presentation, at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place May 7-11, 2024 in Baltimore, MD.
GlobeNewswire Inc. • 1w ago
News News
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -29.27% and 5.64%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 1mo ago
Stocks Earnings Releases and Operating Results
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 3:45 p.m. PT in San Francisco.
GlobeNewswire Inc. • 4mo ago
Stocks Earnings Releases and Operating Results
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
-  Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics
GlobeNewswire Inc. • 5mo ago
Calendar Calendar of Events
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
CAMBRIDGE, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the Jefferies Cell & Genetic Medicine Summit on Tuesday, September 26, 2023 at 9:30 a.m. ET in New York.
GlobeNewswire Inc. • 7mo ago
News News
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of 4.08% and 88.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 9mo ago
Stocks Earnings Releases and Operating Results
Generation Bio Reports Second Quarter 2023 Financial Results
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025 Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025
GlobeNewswire Inc. • 9mo ago
Stocks Earnings Releases and Operating Results
Generation Bio Reports Second Quarter 2023 Financial Results
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025 Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025
GlobeNewswire Inc. • 9mo ago
News News
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Synaptogenix, Inc. (NASDAQ: SNPX) gained 85.5% to $1.6291. Synaptogenix abstract highlighting Bryostatin-1 benefits in severe Alzheimer's disease accepted for presentation at 11th International Brain Research Organization World Congress Of Neuroscience. Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 55.4% to $4.3350. The stock began trading on a 1:18 reverse split on July 10. EdtechX Holdings Acquisition Corp. II (NASDAQ: EDTX) gained 33.2% to $19.00. Snail, Inc. (NASDAQ: SNAL) shares rose 31.2% to $2.1657 after gaining around 3% on Wednesday. 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares gained 29.5% to $6.83. 60 Degrees Pharmaceuticals announced pricing of initial public offering at $5.30 per unit for total of $7.5 million. Fresh Vine Wine, Inc. (NYSE: VINE) rose 25.6% to $0.6546. Moleculin Biotech, Inc. (NASDAQ: MBRX) gained 21% to $0.7424. Moleculin announced publication of data from successful European Phase 1 trial evaluating annamycin as single agent treatment of relapsed or refractory acute myeloid leukemia. Nikola Corporation (NASDAQ: NKLA) climbed 18% to $1.62. Nikola and Bayotech partnered to advance zero-emission hydrogen delivery. Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 17.8% to $0.4841. Hyzon Motors Inc. (NASDAQ: HYZN) climbed 17.8% to $1.3199. Jiayin Group Inc. (NASDAQ: JFIN) gained 17.8% to $6.28. SurgePays, Inc. (NASDAQ: SURG) rose 17.3% to $5.41 as the company issued updates for shareholders. Kingsoft Cloud Holdings Limited (NASDAQ: KC) gained 16.9% to $6.70. Pioneer Power Solutions, Inc. (NASDAQ: PPSI) rose 16.6% to $8.82. Pioneer Power won $6.2 million in E-Bloc orders from new customers to support EV charging and microgrid applications. Wheels Up Experience Inc. (NYSE: UP) climbed 16.4% to $1.6999. Sify Technologies Limited (NASDAQ: SIFY) gained 16.1% to ...
Benzinga • 9mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT